Severe COVID-19 riskier than heart attack for young adults; antibiotic shows no benefit – Yahoo News

By Nancy Lapid( Reuters) – The following is a roundup of some of the latest clinical studies on the novel coronavirus and efforts to discover treatments and vaccines for COVID-19, the health problem triggered by the virus.More young adults make it through heart attacks than extreme COVID-19Among COVID-19 clients dealt with at 419 U.S. medical facilities from April through June, just about 5% were ages 18 to 34. (https://bit.ly/2DHodce, https://bit.ly/3bEsJF8) Antibiotic stops working to help hospitalized COVID-19 patientsThe antibiotic azithromycin did not appear to supply any benefit to hospitalized COVID-19 clients who were having difficulty breathing, according to a study in Brazil. At 57 healthcare facilities, 243 COVID-19 patients who required oxygen or mechanical ventilation were randomly designated to get azithromycin, while 183 comparable patients did not get the antibiotic. According to a paper released on Wednesday in JAMA Network Open, infection control efforts at the hospital included devoted COVID-19 units with airborne infection isolation rooms, individual protective devices for personnel and keeping track of to make sure those were used correctly, universal masking, visitor restriction, and liberal COVID-19 testing of symptomatic and asymptomatic clients. Researchers studied 86 hospitalized COVID-19 clients, 48% of whom had a smoking cigarettes history and 21% of whom needed extensive care.

By Nancy Lapid( Reuters) – The following is a roundup of some of the most current clinical studies on the unique coronavirus and efforts to discover treatments and vaccines for COVID-19, the disease triggered by the virus.More young adults make it through heart attacks than severe COVID-19Among COVID-19 patients dealt with at 419 U.S. health centers from April through June, just about 5% were ages 18 to 34. (https://bit.ly/2DHodce, https://bit.ly/3bEsJF8) Antibiotic stops working to help hospitalized COVID-19 patientsThe antibiotic azithromycin did not appear to supply any advantage to hospitalized COVID-19 clients who were having trouble breathing, according to a study in Brazil. According to a paper released on Wednesday in JAMA Network Open, infection control efforts at the healthcare facility included dedicated COVID-19 systems with air-borne infection seclusion spaces, personal protective devices for staff and keeping an eye on to make sure those were utilized properly, universal masking, visitor constraint, and liberal COVID-19 screening of symptomatic and asymptomatic clients.

Leave a Reply

Your email address will not be published. Required fields are marked *